Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients

Completed

Looking for future studies?

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs
Documented reasons for treatment withdrawal

Exclusion criteria

enrollment in other studies
treatment withdraw for other causes than Tam related AEs

Treatment and study plan

Primary outcomes

incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs

Time frame: January 2003-December 2004

Secondary outcomes

Types of TAM related AE

Time frame: January 2003-December 2004

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: SOSTA

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Aug 4, 2008
Registry last updated: Dec 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed